Systolic hypertension in pregnancy and cardiovascular mortality: A 44-year follow-up study

Hypertension in Pregnancy

Volumn 27, Issue 1, 2008, Pages 87-94

  Luoto, Riitta ^a,b   Kharazmi, Elham ^a   Whitley, Elise ^c   Raitanen, Jani ^a   Gissler, Mika ^d   Hemminki, Elina ^a,d  

^a UNIVERSITY OF TAMPERE   (Finland)

^b UKK INSTITUTE FOR HEALTH PROMOTION RESEARCH   (Finland)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Blood pressure; Cardiovascular Disease; Mortality; Parity; Pregnancy

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DEATH CERTIFICATE; DELIVERY; DIASTOLIC BLOOD PRESSURE; FEMALE; FINLAND; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PARITY; PREGNANCY; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

CARDIOVASCULAR DISEASES; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROTEINURIA; RISK FACTORS; SYSTOLE;

EID: 39749152110     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.1080/10641950701826810     Document Type: Article

References (18)

1. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002; 100(2):369-377.
2. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357(9249):53-56.
3. Hibbard JU. Hypertensive disease and pregnancy. J Hypertens Suppl 2002; 20(2):S29-33.
4. van Pampus MG, Aarnoudse JG. Long-term outcomes after preeclampsia. Clin Obstet Gynecol 2005; 48(2):489-494.
5. Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995; 74(10):772-776.
6. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323(7323):1213-1217.
7. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001; 357(9273):2002-2006.
8. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Risk factors and clinical manifestations of pre-eclampsia. BJOG 2000; 107(11):1410-1416.
9. Black HR. The paradigm has shifted to systolic blood pressure. J Hum Hypertens 2004; 18 Suppl 2:S3-7.
10. Martin JN, Jr, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105(2):246-254.
11. Hemminki E, Gissler M, Toukomaa H. Exposure to female hormone drugs during pregnancy: effect on malformations and cancer. Br J Cancer 1999; 80(7):1092-1097.
12. Hemminki E, Gissler M, Merilainen J. Reproductive effects of in utero exposure to estrogen and progestin drugs. 1999; 71(6):1092-1098.
13. Seely EW. Hypertension in pregnancy: a potential window into long-term cardiovascular risk in women. J Clin Endocrinol Metab 1999; 84(6):1858-1861.
14. Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart 1997; 77(2):154-158.
15. Arnadottir GA, Geirsson RT, Arngrimsson R, Jonsdottir LS, Olafsson O. Cardiovascular death in women who had hypertension in pregnancy: a case-control study. BJOG 2005; 112(3):286-292.
16. Gifford R. Working Group Report on High Blood Pressure and Pregnancy. Washington, DC: National Institutes of Health; 2000: NIH publication No. 00-3029 2000;00-3029.
17. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003; 326(7394):845.
18. Kaaja R, Greer I. Manifestations of chronic disease during pregnancy. JAMA 2005;294:2975-9.